Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4561411
Max Phase: Preclinical
Molecular Formula: C30H32Cl2F3N7O5
Molecular Weight: 584.51
Molecule Type: Unknown
Associated Items:
ID: ALA4561411
Max Phase: Preclinical
Molecular Formula: C30H32Cl2F3N7O5
Molecular Weight: 584.51
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN(C)CC/C=C/C(=O)Nc1ccc(N2CC[C@@H](NC(=O)c3n[nH]cc3NC(=O)c3c(Cl)cccc3Cl)C2)cc1.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C28H31Cl2N7O3.C2HF3O2/c1-36(2)14-4-3-8-24(38)32-18-9-11-20(12-10-18)37-15-13-19(17-37)33-28(40)26-23(16-31-35-26)34-27(39)25-21(29)6-5-7-22(25)30;3-2(4,5)1(6)7/h3,5-12,16,19H,4,13-15,17H2,1-2H3,(H,31,35)(H,32,38)(H,33,40)(H,34,39);(H,6,7)/b8-3+;/t19-;/m1./s1
Standard InChI Key: SXGSVRQWHVYATD-FGTSTTERSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 584.51 | Molecular Weight (Monoisotopic): 583.1865 | AlogP: 4.42 | #Rotatable Bonds: 10 |
Polar Surface Area: 122.46 | Molecular Species: BASE | HBA: 6 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 10.75 | CX Basic pKa: 9.45 | CX LogP: 4.47 | CX LogD: 2.59 |
Aromatic Rings: 3 | Heavy Atoms: 40 | QED Weighted: 0.26 | Np Likeness Score: -1.55 |
1. Ferguson FM, Doctor ZM, Ficarro SB, Marto JA, Kim ND, Sim T, Gray NS.. (2019) Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14., 29 (15): [PMID:31175010] [10.1016/j.bmcl.2019.05.024] |
Source(1):